Clinical trial
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate…
NCT00230386 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00230386 |
|---|---|
| Title | Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma |
| Official title | The Role of MRI Perfusion to Detect Locally Recurrent or Persistent Disease in Prostate Carcinoma Treated With Radiation Therapy - A Pilot Study |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Princess Margaret Hospital, Canada |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms |
| Intervention type | Device |
| Interventions | MRI |
| Enrollment | 50 |
| Start date | May 1, 2003 |
| First posted | Sep 30, 2005 |
| Last update posted | Jul 14, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: